Literature DB >> 10845484

Initial experience with contrast-enhanced sonography of the prostate.

E J Halpern1, L Verkh, F Forsberg, L G Gomella, R F Mattrey, B B Goldberg.   

Abstract

OBJECTIVE: We investigated the usefulness of contrast-enhanced sonography to depict vascularity in the prostate and improve the detection of prostatic cancer. SUBJECTS AND METHODS: Twenty-six patients with an elevated prostate-specific antigen level (> or = 4 ng/ml) or an abnormal digital rectal examination were enrolled in a phase II study of an i.v. injected sonographic contrast agent. Continuous gray-scale, intermittent gray-scale, phase inversion gray-scale, and power Doppler sonography of the prostate were performed. Sonographic findings were correlated with sextant biopsy results.
RESULTS: After the administration of contrast material, gray-scale and Doppler images revealed visible enhancement (p < 0.05). Using intermittent imaging, we found focal enhancement in two isoechoic tumors that were not visible on baseline images. No definite focal area of enhancement was identified in any patient without cancer. Contrast-enhanced images revealed transient hemorrhage in the biopsy tracts of three patients.
CONCLUSION: Enhancement of the prostate can be seen on gray-scale and Doppler sonographic images after the administration of an i.v. contrast agent. Contrast-enhanced intermittent sonography of the prostate may be useful for the selective enhancement of malignant prostatic tissue.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10845484     DOI: 10.2214/ajr.174.6.1741575

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  17 in total

1.  Contrast-enhanced ultrasound imaging of prostate cancer.

Authors:  Ethan J Halpern
Journal:  Rev Urol       Date:  2006

2.  Multimodal Imaging in Focal Therapy Planning and Assessment in Primary Prostate Cancer.

Authors:  Hossein Jadvar
Journal:  Clin Transl Imaging       Date:  2017-04-10

Review 3.  Ultrasonography in prostate cancer: current roles and potential applications in radiorecurrent disease.

Authors:  James S Rosoff; Sandip M Prasad; Stephen J Savage
Journal:  World J Urol       Date:  2013-05-01       Impact factor: 4.226

Review 4.  [Ultrasound contrast agents and prostate cancer].

Authors:  F Frauscher; L Pallwein; A Klauser; A P Berger; F Koppelstaetter; J Gradl; M Schurich; J Bektic; G M Pinggera; E J Halpern; W Horninger; G Bartsch; D zur Nedden
Journal:  Radiologe       Date:  2005-06       Impact factor: 0.635

5.  Acoustic radiation force impulse imaging of human prostates: initial in vivo demonstration.

Authors:  Liang Zhai; Thomas J Polascik; Wen-Chi Foo; Stephen Rosenzweig; Mark L Palmeri; John Madden; Kathryn R Nightingale
Journal:  Ultrasound Med Biol       Date:  2011-11-21       Impact factor: 2.998

6.  Prostate cancer: risk assessment and diagnostic approaches.

Authors:  L G Gomella; F Labrie; E J Gamito; M K Brawer
Journal:  Rev Urol       Date:  2001

7.  Prostate cancer: serum and tissue markers.

Authors:  G J Miller; M K Brawer; W A Sakr; J B Thrasher; R Townsend
Journal:  Rev Urol       Date:  2001

Review 8.  Image guidance for focal therapy of prostate cancer.

Authors:  U Lindner; N Lawrentschuk; J Trachtenberg
Journal:  World J Urol       Date:  2010-10-21       Impact factor: 4.226

Review 9.  Contrast specific imaging in the detection and localization of prostate cancer.

Authors:  Hessel Wijkstra; Margot H Wink; Jean J M C H de la Rosette
Journal:  World J Urol       Date:  2004-10-05       Impact factor: 4.226

10.  Modalities for imaging of prostate cancer.

Authors:  A H Hou; D Swanson; A B Barqawi
Journal:  Adv Urol       Date:  2010-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.